Published in

SAGE Publications, Journal of Psoriasis and Psoriatic Arthritis, 2(1), p. 86-89, 2016

DOI: 10.1177/247553031600100207

Links

Tools

Export citation

Search in Google Scholar

Physician Satisfaction with Current Psoriasis Treatment: A Real-World Study in the USA

Journal article published in 2016 by Neil J. Korman, Yang Zhao, Jenna Roberts, James Pike, Emma Sullivan ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Background Dermatologists may provide a unique perspective on psoriasis management by offering an evaluation of satisfaction with disease control. Objectives To examine physician satisfaction with psoriasis control. Methods Data were extracted from the Adelphi 2011/2013 Psoriasis Disease Specific Programmes, two real-world U.S. surveys of dermatologists. For individual patients, physicians reported treatment history, disease severity, symptom severity for itching, pain and scaling, and their satisfaction level (satisfied vs. dissatisfied). Results Dermatologists were dissatisfied with disease control for 28.6% of patients. When physicians were dissatisfied, patients were more likely to currently have moderate (66% vs. 33%) or severe (20% vs. 2%) psoriasis compared to patients with satisfied physicians (p<0.05). Patients with dissatisfied physicians were also more likely to currently have more severe pain, itching and scaling, and were less likely to be receiving a biologic therapy (all p<0.05). Conclusion Dermatologists were dissatisfied with the control achieved for more than one-quarter of their psoriasis patients.